Agoracom: Small Cap Investment - Resverlogix Corp.

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Re: Interim Analysis

barsax

Oct 15, 2020 08:26PM

Re: Interim Analysis

barsax

Oct 16, 2020 09:29AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Interim Analysis

in response to

Re: Interim Analysis

barsax

posted on Oct 16, 2020 09:58AM

It seems that are several SGLT2 inhibitor drugs that offer MACE as an added benefit at no extra cost to the patient.

Comments welcomed from the medical group on this forum in this regard.

Koo

2 Recommendations

Re: Interim Analysis

cityslicker99

Oct 16, 2020 05:21PM

Reply New Message

Back To Forum List View

Please to post a reply